Catalyst Wire Dossier Catalyst Wire Dossier

RV1162

· Respivert Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RV1162, covering 2014-11-20 to 2014-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD Patients [Phase 1]

See pricing